Latest News for: vertex

Edit

Statement of Changes in Beneficial Ownership (Form 4) (Vertex Inc)

Public Technologies 24 Feb 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10 ... Washington, D.C ... OMB Number ... Vertex, Inc ... C/O VERTEX, INC., 2301 RENAISSANCE BLVD 3 ... C/O VERTEX, INC ... Vertex Inc.
Edit

Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K) (Vertex Inc)

Public Technologies 24 Feb 2026
Vertex is a leading provider of enterprise compliance technology for global commerce ... Headquartered in North America, and with offices in South America and Europe, Vertex employs over 2,100 professionals and serves companies across the globe.
Edit

Form 10-K (0001104659 26 019165) (Vertex Inc)

Public Technologies 24 Feb 2026
001-39413 VERTEX, INC ... The aggregate market value of the voting and non-voting common equity held by non-affiliates of Vertex, Inc ... Throughout this Annual Report on Form 10-K, Vertex, Inc ... Vertex AI ... Vertex Inc.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Vertex Pharmaceuticals Incorporated)

Public Technologies 23 Feb 2026
VERTEX PHARMACEUTICALS INC / MA [VRTX] 5 ... C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE 3 ... C/O VERTEX PHARMACEUTICALS INCORPORATED ... Vertex Pharmaceuticals Incorporated published this ...
Edit

Initial Quarterly Holdings Report by Institutional Manager (Form 13F-HR) (Vertex Planning Partners LLC)

Public Technologies 17 Feb 2026
) ... The reader should not assume that the information is accurate and complete ... 20549 ... Vertex Planning Partners, LLC ... Vertex Planning Partners LLC published this content on February 17, 2026, and is solely responsible for the information contained herein.
Edit

Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K) (Vertex Pharmaceuticals Incorporated)

Public Technologies 13 Feb 2026
OPERATIONS ... Cash ... The FDA awarded Vertex with a Commissioner's National Priority Voucher for this pediatric ... Vertex Pharmaceuticals Incorporated published this content on February 13, 2026, and is solely responsible for the information contained herein.
Edit

Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue

The Call 12 Feb 2026
Biotech company Vertex Pharmaceuticals (NASDAQ ... Is now the time to buy Vertex Pharmaceuticals? Find out by accessing our full research report, it’s free. Vertex Pharmaceuticals (VRTX) Q4 CY2025 Highlights..
Edit

Vertex Reports Fourth Quarter and Full Year 2025 Financial Results (Form 8-K) (Vertex Pharmaceuticals Incorporated)

Public Technologies 12 Feb 2026
) Vertex Reports Fourth Quarter and Full Year 2025 Financial Results ... BOSTON -- Vertex Pharmaceuticals Incorporated (Nasdaq ... operating activities, partially offset by repurchases of Vertex's common stock pursuant to its share repurchase programs.
Edit

Vertex Reports Fourth Quarter and Full Year 2025 Financial Results (Vertex Pharmaceuticals Incorporated)

Public Technologies 12 Feb 2026
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results ... 12, 2026-- Vertex Pharmaceuticals Incorporated (Nasdaq ... Vertex today provided full year 2026 financial guidance ... Vertex's financial guidance is summarized below.
×